4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide, 98.0%, 5g

3-Ethoxy-2,2-dimethylpropan-1-amine, 97%, 10g

GC capillary column ROTI®Cap-5, 60 m, 0.53 mm, 2.00 µm, 1 Piece(s)

(R)-3-Amino-1-butanol>98.0%(GC)(T)1g

Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(3-methoxyphenoxy)-4-pyrimidinyl]-, 50mg

3,6-Dichloro-5-nitropyridazin-4-amine, 95.0%, 10g

3-(3-Fluoro-2-methoxyphenyl)propionic acid, 250mg

(2-Bromo-5-chloropyridin-4-yl)boronic acid, 95.0%, 10g

N-Methyl-4-nitrobenzenesulfonamide, 95.0%, 5g

5-Chloro-3-(2-fluorophenyl)-1,2,4-oxadiazole, 96%, 100mg

(1-(tert-Butoxycarbonyl)piperidin-4-yl)boronic acid, 1g

Paraldehyde>98.0%(GC)500mL

3-Fluoro-2-nitrobenzoic acid ethyl ester, 95.0%, 5g